drugset / Trial / NCT06222723

LAssa Fever Adjunct Treatment With DEXamethasone

NCT06222723

Phase 2 Recruiting 42 enrolled Bernhard Nocht Institute for Tropical Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

Dexamethasone is a corticosteroid which can modulate inflammatory-mediated tissue damage associated with a wide range of infectious diseases. Dexamethasone is routinely used for treatment of tuberculous meningitis and for pneumococcal meningitis in adults. In Coronavirus Disease 2019 (COVID-19) dexamethasone is also effectively preventing immune mediated damage of the lungs. There is also indication that dexamethasone may be promising in severe LF.

Timeline

Start
2024-02-05
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Intravenous
Background Ribavirin Small molecule Intravenous

Indications